Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Versus Long-Acting Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients

NCT05699109 is registered in ClinicalTrials.gov with Helwan University as lead sponsor.

NCT NCT05699109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05699109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Versus Long-Acting Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients
Lead sponsor
Helwan University
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
September 30, 2021
Enrollment
127 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia of chronic kidney disease, chronic renal failure, chronic renal failure anemia